Tech Company Financing Transactions
Kamari Pharma Funding Round
Kamari Pharma, based in Ness Ziona, secured $8 million in funding from GIBF2.
Transaction Overview
Company Name
Announced On
9/19/2022
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Undisclosed
Investors
GIBF2 (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate growth and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Pinchas Sapir 3, Science Park
Ness Ziona, Undisclosed
IL
Ness Ziona, Undisclosed
IL
Phone
Website
Email Address
Overview
Kamari Pharma was founded in 2018 to develop innovative treatments for unmet needs and rare diseases in dermatology. We are developing proprietary small molecules, selective TRPV3 inhibitors for regulation of skin physiology and pathology. We are aiming to treat conditions of the skin with no current treatments by targeting the root cause of Ca++ dysregulation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
David Aviezer
Chief Financial Officer
Asaf Yarkoni
Chief Scientific Officer
Liora Braiman
Browse more venture capital transactions:
Prev: 9/19/2022: Swiftly Systems venture capital transaction
Next: 9/19/2022: CoverTree venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs